menu search

Todos medical says tollovid receives lgc group's informed sport certification as it targets athlete support

Todos Medical Ltd. (OTCQB:TOMDF) has announced that its majority-owned subsidiary 3CL Pharma Ltd has received LGC Group's Informed Sport Certification...

April 19, 2022, 8:13 am

Inmune (inmb) begins dosing in mid-stage study with ad candidate

INmune (INMB) doses the first patient in a phase II study with its investigational TNF inhibitor to tre...

April 14, 2022, 5:19 pm

Late-stage biopharmaceutical sierra oncology announces acquisition by gsk

Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share i...

April 13, 2022, 1:49 pm

Hookipa shares jump on new preclinical data on cancer immunotherapies

HOOKIPA Pharma Inc (NASDAQ: HOOK) has announced preclinical data demonstrating potent T cell responses, combination use beyond PD-1 inhi...

April 13, 2022, 11:52 am

Syros' cdk12 inhibitor shows anti tumor activity in preclinical studies

Syros Pharmaceuticals Inc (NASDAQ: SYRS) announced new preclinical data from its CDK12 inhibitor pro...

April 11, 2022, 9:30 am

Repare therapeutics to present new clinical and preclinical data at the 2022 aacr annual meeting

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage pr...

April 8, 2022, 1:00 pm

Ocuphire pharma to present at wet amd & dme drug development summit in boston, ma

FARMINGTON HILLS, Mich., April 06, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical compan...

April 6, 2022, 8:00 am

Todos medical says tollovir and tollovid show robust inhibitory activity against 3cl protease of strains of omicron variant

Todos Medical Ltd said its majority-owned subsidiary 3CL Pharma Ltd announced that its mechanism-based 3CL protease inhi...

April 4, 2022, 10:35 am

Sellas life sciences stock plunges after $25m capital raise via equity, in-licenses cancer-focused cdk9 inhibitor

GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc (NASDAQ: SLS) across all therapeutic and diagnostic uses worldwi...

April 1, 2022, 8:58 am

Arca biopharma's tissue factor inhibitor disappoints in mid-stage covid-19 study

ARCA biopharma Inc (NASDAQ: ABIO) announced results from the ASPEN-COVID-19 Phase 2 trial evaluating rNAPc2, a specific inhi...

April 1, 2022, 7:21 am

Todos medical reports case study of patient with long covid who used its dietary supplement tollovid after doctor recommendation

Todos Medical Ltd announced that its majority-owned subsidiary 3CL Pharma, Ltd is reporting a case study from a patient with long COVID who was re...

March 31, 2022, 1:57 pm

Neo battery materials provides corporate update including on full cell testing with nbmside, and the near completion of its r&d scale-up centre

NEO Battery Materials Ltd has provided corporate updates on InterBattery 2022, full cell testing updates with high energy capacity NBMSiDE, and the ne...

March 31, 2022, 12:26 pm

Astrazeneca's ondexxya wins approval for reversal of acute major bleeds in patients

AstraZeneca PLC (LSE:AZN) said its Ondexxya treatment was approved in Japan, the first approved reversal agent specifically for Factor Xa inhi...

March 29, 2022, 5:31 am

Analysts cut price target on mei pharma as stock falls to 52-week low after zandelisib update

The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibito<...

March 25, 2022, 2:51 pm

4d pharma sees early success as phase i/ii cancer trial hits its efficacy target early

4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) said it had hit its primary efficacy target in a phase I/II trial of one of its lead assets in kidney cancer. MR...

March 23, 2022, 3:56 am

Respirerx pharmaceuticals notes publication of paper on newest gabakine analog which protects against seizures and lethality

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc has noted the publication of a paper detailing the company's newest candidate D5-KRM-II-81, which is a so-c...

March 17, 2022, 9:49 am

Amc buying 22% of gold, silver miner hycroft

AMC Entertainment Holdings Inc. ( AMC , Financial), the largest theatrical exhibitor in the United Stat...

March 15, 2022, 2:56 pm

Shattuck labs to present two posters at the 2022 american association for cancer research (aacr) annual meeting

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa...

March 9, 2022, 8:21 am

Nuvalent to present new preclinical data on ros1-selective inhibitor nvl-520 and alk-selective inhibitor nvl-655 at aacr annual meeting 2022

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Nuvalent, Inc., (Nasdaq: NUVL) a biotechnology company creating precisely targeted therapies for clin...

March 8, 2022, 5:38 pm

Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual

CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...

March 8, 2022, 5:01 pm


Search within

Pages Search Results: